^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

cyclosporine

Company:
Generic mfg.
Drug class:
Calcineurin inhibitor
3d
The Use of Naltrexone to Successfully Treat Severe Hailey-Hailey Disease. (PubMed, Cureus)
In 2022, acitretin was commenced and uptitrated to 25 mg once daily...Other immunosuppressive agents, such as methotrexate, cyclosporine, and azathioprine, have been described in the literature with varying efficacy...Naltrexone is postulated to work due to its analgesic and anti-inflammatory effects. It is a well-tolerated treatment for severe HHD that has drastically improved both our patient's skin and his quality of life.
Journal
|
IL6 (Interleukin 6) • TLR4 (Toll Like Receptor 4)
|
methotrexate • cyclosporine • naltrexone
6d
T-cell large granular lymphocyte leukaemia with pure red cell aplasia harbouring a somatic STAT3 P715L mutation. (PubMed, BMJ Case Rep)
The patient responded to ciclosporin therapy with gradual haematological improvement and became transfusion-independent within 6 months. This case highlights the importance of molecular profiling in T-LGLL presentations and expands the known mutational spectrum of STAT3 It also raises the possibility that non-SH2 (Src homology 2) domain STAT3 mutations may contribute to disease pathogenesis and influence treatment response in T-LGLL.
Journal
|
CD8 (cluster of differentiation 8) • STAT3 (Signal Transducer And Activator Of Transcription 3)
|
STAT3 mutation
|
cyclosporine
8d
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis (clinicaltrials.gov)
P4, N=10, Not yet recruiting, University of California, San Francisco | Initiation date: Jan 2026 --> Aug 2026
Trial initiation date
|
5-fluorouracil • Jakafi (ruxolitinib) • hydroxychloroquine • cyclosporine • roflumilast • tofacitinib • Cosentyx (secukinumab) • Dupixent (dupilumab) • Ilumya (tildrakizumab-asmn) • chloroquine phosphate
8d
Trial completion
|
Chr del(5q)
|
etoposide IV • busulfan • cyclosporine
9d
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders (clinicaltrials.gov)
P2, N=260, Active, not recruiting, City of Hope Medical Center | Trial completion date: Apr 2026 --> Mar 2027
Trial completion date
|
HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1) • HLA-B (Major Histocompatibility Complex, Class I, B)
|
cyclophosphamide • etoposide IV • sirolimus • melphalan • fludarabine IV • busulfan • cyclosporine
14d
Eosinophilic fasciitis: a comprehensive systematic review of clinical, histologic, and therapeutic perspectives. (PubMed, Ital J Dermatol Venerol)
This review provides a systematic analysis of the clinical, biological, and histological characteristics of EF, its associated triggers, and therapeutic strategies based on a comprehensive review of reported cases. We found that poor prognostic factors include diagnostic delay (>6 months), trunk involvement, early-onset disease (<12 years), and morphea-like skin lesions.
Journal
|
IL5 (Interleukin 5)
|
Rituxan (rituximab) • methotrexate • hydroxychloroquine • cyclosporine
18d
Safety Profile of Systemic Therapy for the Management of Psoriasis in Patients With Diabetes Mellitus: Data From the BIOBADADERM Prospective Cohort. (PubMed, Actas Dermosifiliogr)
Among patients with psoriasis and DM, APR was associated with a lower incidence of DM-AEs, whereas cyclosporine and acitretin were associated with higher incidences compared with MTX.
Journal
|
IL17A (Interleukin 17A) • IL23A (Interleukin 23 Subunit Alpha)
|
methotrexate • cyclosporine
1m
Methods of T Cell Depletion Trial (MoTD) (clinicaltrials.gov)
P2, N=400, Recruiting, University of Birmingham | Trial completion date: Jan 2026 --> Aug 2027 | Trial primary completion date: Jan 2026 --> Aug 2027
Trial completion date • Trial primary completion date
|
cyclophosphamide • sirolimus • cyclosporine • methylprednisolone sodium succinate
1m
New P2 trial
|
TP53 (Tumor protein P53) • KMT2A (Lysine Methyltransferase 2A)
|
cyclophosphamide • clofarabine • fludarabine IV • thiotepa • busulfan • cyclosporine
1m
New P1 trial
|
cyclosporine • efavirenz • omeprazole
1m
Safety and Clinical Outcomes of Pooled Donor, Nonengrafting Expanded Progenitor Cells in Single-Unit Cord Blood Transplantation. (PubMed, J Clin Oncol)
The addition of dilanubicel to single-unit CBT demonstrated a favorable safety profile, with no severe acute or chronic GVHD, and was associated with excellent clinical outcomes. These findings support further investigation of this strategy.
Clinical data • Journal
|
CD34 (CD34 molecule)
|
cyclosporine • dilanubicel (DVX101)